BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3708872)

  • 1. Effect of oral contraceptives on serum prolactin: a longitudinal study in 126 normal premenopausal women.
    Hwang PL; Ng CS; Cheong ST
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):127-33. PubMed ID: 3708872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
    Snowden EU; Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indicators of arterial blood pressure during hormonal contraception].
    Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1985 Aug; (9):56-7. PubMed ID: 2416229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
    Dubnitskaia LV; Sotnikova EI
    Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
    Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
    Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions.
    Silber M; Almkvist O; Larsson B; Stock S; Uvnäs-Moberg K
    Contraception; 1987 Dec; 36(6):641-50. PubMed ID: 3128427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum copper and zinc in hormonal contraceptive users.
    Prema K; Ramalakshmi BA; Babu S
    Fertil Steril; 1980 Mar; 33(3):267-71. PubMed ID: 6444895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO; Andersen O; Kühl C
    Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
    Mohan Ram M; Bamji MS
    Am J Obstet Gynecol; 1979 Oct; 135(4):470-2. PubMed ID: 573554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.